Live
Home·Deals·Consumer Healthcare·Hims acquires Eucalyptus
Hims acquires Eucalyptus (2026)
SEO URLwww.firestrike.ai/deals/eucalyptus-hims-acquisition-2026-18
acquisitionAnnounced · Feb 23, 2026Consumer HealthcareSource · CredibleArticle · Factual
Eucalyptus
Hims
Eucalyptus · Hims

Hims acquires Eucalyptus

David Najork
David Najork · Founding Software Engineer
Announced · Updated · 2 min read
ShareXLinkedInEmail
Deal value
$1.15B
Target
Eucalyptus
Eucalyptus
Acquirer
Hims
Hims
Full Acquisition
Status
Pending

Hims & Hers Health, Inc. has agreed to acquire Eucalyptus, an Australian consumer healthcare platform, for approximately USD 1.1 billion. This transaction marks a significant expansion for the San Francisco-based telehealth company into international markets, leveraging Eucalyptus’s existing infrastructure and user base to bolster Hims & Hers' global presence in consumer healthcare.

The acquisition involves a cash-and-stock transaction, positioning Hims & Hers to capitalize on Eucalyptus’s suite of online health brands and services that span skincare, sexual health, and fertility solutions. By integrating Eucalyptus's offerings, Hims & Hers aims to diversify its product portfolio while tapping into new demographics, particularly in the Asia-Pacific region. The deal reflects Hims & Hers’ strategic plan to broaden its global outreach and enhance its digital health capabilities.

The rationale behind this acquisition aligns with Hims & Hers' strategic focus on expanding its range of services and geographies. Andrew Dudum, CEO of Hims & Hers, highlighted the complementary nature of Eucalyptus’s core competencies, noting that the move will provide immediate access to established markets and streamline the company’s entry into new sectors. This acquisition is expected to enhance service delivery and customer engagement across Hims & Hers' existing and new platforms, diversifying revenue streams and potentially accelerating growth.

In the context of the consumer healthcare sector, this acquisition underscores a trend of consolidation aimed at creating scalable, comprehensive digital health platforms catering to personal and preventative care. As telehealth continues to gain traction, the Hims & Hers-Eucalyptus deal may prompt competitors to reevaluate their own market positions and consider similar expansion strategies or partnerships to remain competitive.

Pending regulatory approvals, the acquisition is anticipated to close by mid-2024. A seamless integration will be critical to realizing the anticipated synergies. As Hims & Hers expands its foothold with this acquisition, industry observers will be watching closely to see how this move influences the competitive landscape and market dynamics in consumer healthcare, particularly in digital services.

Deal timeline

Announced
Feb 23, 2026 · finance.yahoo.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Consumer Healthcare with a reported deal value of $1.15B. Figures and status may change as sources update.

Sources: finance.yahoo.com · Primary article · FireStrike proprietary index